Information
Qrem is a start-up engaged to regenerative medicine that develops, manufactures and markets medical devices.
Its mission is to promote the standardization and scalability of autologous regenerative therapies, making available to physicians Lab-in-a-Box bioengineering systems and companion diagnostics (CDx) based on AI to carry out these therapies with high cost-effectiveness ratio.
Qrem Cytokine, the first product of the company in commercialization since 2019, obtains a Cytokine Rich Serum from the patient's blood which is infiltrated locally in the area to be treated. Currently carrying out two R&D projects based on CDx for knee osteoarthritis and prevention/cure of complex wounds.
Its mission is to promote the standardization and scalability of autologous regenerative therapies, making available to physicians Lab-in-a-Box bioengineering systems and companion diagnostics (CDx) based on AI to carry out these therapies with high cost-effectiveness ratio.
Qrem Cytokine, the first product of the company in commercialization since 2019, obtains a Cytokine Rich Serum from the patient's blood which is infiltrated locally in the area to be treated. Currently carrying out two R&D projects based on CDx for knee osteoarthritis and prevention/cure of complex wounds.
Key Information
-
Growth Stage
-
CountrySpain
-
Founding Year2016